Brain Disorders & Therapy

The future of health outcome measurements of brain disorders

6^th International Conference on Brain Disorders and Therapeutics

September 13-15, 2018 | Copenhagen, Denmark

Kim Baden Kristensen

Brain, Denmark

Scientific Tracks Abstracts: Brain Disord Ther

Abstract:

As our knowledge of brain disorders evolves, with new studies shedding new light on the underlying mechanisms and as new technologies become available that offer new means of measuring and collecting data, we need to evolve the way we measure, quantify, test brain disorders and the way we design and use health outcome measures, both in clinical practice and in scientific studies. In this workshop we will cover, discuss and analyze topics such as; patient reported outcomes, use of real world data and evidence, psychometric measures and tests, cognitive measures and tests, behavioral measures and tests, and more. The aim of the workshop is to share knowledge and map the possible future evolution of health outcome measures related to brain disorders.

Biography :

Kim Baden Kristensen is the CEO and Co-founder of Brain+, which specializes in digital therapeutics for brain rehabilitation and remediation, specifically for the recovery of impaired cognitive functions due to injury or disease. Its award winning Brain+ apps are being clinically tested in Parkinson’s disease, major depressive disorder and traumatic brain injury patients, and is being used by Danish national team athletes to enhance cognitive performance. Brain+ is also working on pre-symptomatic detection of Alzheimer’s disease in collaboration with leading European universities, providers, and patient organizations.

E-mail: kim@brain-plus.com